Rx data firms sue Maine, Vermont

Share this article:
Three firms are challenging Maine and Vermont over new state laws that restrict the collection and disclosure of physician prescribing information.

IMS Health, Wolters Kluwer Health and Verispan want to prevent statutes in the two states from taking effect Jan. 1.

A similar New Hampshire law that would have limited drug company access to doctors' prescribing habits was struck down in U.S. District Court in April on constitutional grounds. That ruling is under appeal.

The suits, filed in late August, say the Maine and Vermont statutes differ only slightly from the New Hampshire law and that they deny access to information that is central to improving the quality of care and ensuring patient safety.

But Vermont and Maine officials said that after the New Hampshire ruling, they altered their laws and would fight the lawsuit. “We will vigorously defend the constitutionality of the law and oppose efforts to have its enforcement enjoined,” Maine's attorney general told the AP.

Share this article:

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union